Literature DB >> 25857506

Antibody response to hepatitis B vaccination in isolated anti-HBc positive subjects.

Hasan Tahsin Gozdas1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25857506      PMCID: PMC4405929          DOI: 10.4103/0971-5916.154516

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


× No keyword cloud information.
Sir, I read with interest the article by Sugunan et al1 on impact of hepatitis B immunization among the Nicobarese tribe. The authors investigated protective antibody response after hepatitis B vaccination in their study. I feel that several points in this study need to be clarified. Hepatitis B infection has been reported to be hyperendemic in Nicobarese where this study was conducted. As per the inclusion criteria, subjects negative for both HBsAg and Anti-HBs were included in the study. However, hepatitis B core antibody (anti-HBc) status of the study population was not mentioned. This condition could be a confounding factor. Because hepatitis B vaccine is not recommended for isolated anti-HBc positive subjects (HBsAg and anti-HBs negative) living in highy endemic areas due to the high probability of previous exposure to hepatitis B infection2. Isolated anti-HBc positivity might be present in these subjects who were at high risk for prior exposure to hepatitis B infection. Antibody response after hepatitis B vaccination may be different in isolated anti-Hbc positive subjects from that of naive subjects3. In addition, primary anti-HBs response develops when anti-HBc was positive at a low titre; whereas secondary or anamnestic antibody response develops when anti-HBc was positive at a high titre34. Subjects enrolled in this study might be heterogeneous in terms of anti-Hbc status due to sampling error. Further in this study1, protective antibody level was tested one month after each vaccine dose and after the completion of vaccine series at second, third and fifth year. As understood from the Figure, protective antibody level after the third vaccine dose was tested at sixth month rather than the seventh month. However, as mentioned in the article, protective levels should have been checked one month after each vaccine dose (after the third dose of vaccine at seventh month not at sixth month). I think there is a typographical error in the figure.
  4 in total

1.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

2.  Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs.

Authors:  A S Lok; C L Lai; P C Wu
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

3.  Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen.

Authors:  B J McMahon; A J Parkinson; C Helminiak; R B Wainwright; L Bulkow; A Kellerman-Douglas; S Schoenberg; D Ritter
Journal:  Gastroenterology       Date:  1992-08       Impact factor: 22.682

4.  Impact of hepatitis B immunization among the Nicobarese tribe--antibody titres & seroprotection five years after vaccination.

Authors:  A P Sugunan; Haimanti Bhattacharya; Debdutta Bhattacharya; A Mandal; S R Ghosal; R C Rao; A K Mandal
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.